Amid ongoing controversies involving misuse of information about its users, Facebook has shelved plans to share user data with several major U.S. hospitals. CNBC reported the social media giant had scientists approach organizations, including the American College of Cardiology, about the project.

According to a new study in JAMA, people who lost at least 75 percent of their net worth in a two-year period showed a 50 percent increased risk of dying over two decades compared to those who maintained positive wealth.

Outcomes-based pricing agreements would do little to help the poor cost-effectiveness of PCSK9 inhibitors. The event rates in preventive medicine are simply too low and medication costs too high for such a compromise to make a difference, a group from University of California, San Francisco reported in the Annals of Internal Medicine.

GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.

The number of patients admitted to U.S. hospitals for infective endocarditis (IE) related to IV drug use has more than doubled over the last several years, racking up an average of $72,000 in expenses each time.

In a blog published March 29 by Health Affairs, four researchers expressed the need for creative reimbursement systems to “promote accountability” for outcomes related to devices that treat cardiovascular disease (CVD).

Death rates from heart disease decreased by 68 percent for Americans from 1968 to 2015, according to a new analysis, but the mortality decline was greater for whites than blacks.

Diagnosed diabetes in the U.S. cost a total of $327 billion in 2017, according to a new report commissioned by the American Diabetes Association published online March 22 in Diabetes Care.